Delivery Order SPE2DR25D3501-SPE2DR26FM2PB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance based in Conshohocken, Pennsylvania and an ultimate completion date of December 26, 2025. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccines (12 years and up) in 0.5ml syringes, with a completion date of January 2, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,052.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes, with an ultimate completion date of January 2, 2026. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,579.20 for Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes, with a completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was executed on December 8, 2025, with an ultimate completion date of December 30, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,613.65 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up), 0.5mL syringes, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,202.77 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and older), 0.5ml syringes, with an ultimate completion date of December 5, 2025. This is a firm fixed price, non-set-aside contract performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,579.17 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up), 0.5mL syringes, with an ultimate completion date of December 30, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle that runs through December 2026 and serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,987.50 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was issued on November 18, 2025, with an ultimate completion date of December 10, 2025. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $16,488.75 delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringe format. This competitively awarded, firm fixed-price delivery order was issued on December 19, 2025, with an ultimate completion date of January 13, 2026. The contract will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. As a child delivery order,...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM2PBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,211.20 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up), 0.5 milliliter syringes, with a firm fixed price and an ultimate completion date of February 6, 2026. This non-set-aside contract was competitively awarded on January 15, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger Indefinite Delivery Contract vehicle—the DLA Troop Support Medical SPE2DX prime vendor contract—which is valued at up to $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal medical procurement vendor with an extensive portfolio of vaccine and pharmaceutical deliveries to the Defense Logistics Agency and other government healthcare systems. The company's federal contract performance demonstrates capability in fulfilling diverse medical supply needs across multiple therapeutic domains, including vaccines, specialty medications, and branded and generic drugs. This delivery order for Spikevax vaccine aligns with the company's core business of supplying essential pharmaceutical commodities to support military treatment facilities and federal health programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 1/14/26 |